{"id":"W4396872898","doi":"10.1182/bloodadvances.2024012880","title":"Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Daiichi Sankyo Europe; National Cancer Institute; Genentech; Servier; Astellas Pharma; Galecto; CTI Biopharma; Taiho Pharmaceutical; Incyte; Astex Pharmaceuticals; Gilead Sciences; GlaxoSmithKline; MorphoSys; Celgene; Bristol-Myers Squibb; AstraZeneca; Pfizer; National Center for Advancing Translational Sciences; Agios Pharmaceuticals","keywords":"Medicine; Internal medicine; Oncology; Venetoclax; Myeloid; Myeloid leukemia; Chemotherapy; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003373628,0.0001146912,0.0001833453,0.0002733967,0.0002739062,0.0004193839,0.0001567409,0.0002423347,0.001065328],"category_scores_gemma":[0.0008289085,0.00004622537,0.0001911841,0.0004287022,0.0001424851,0.0003539039,0.0002714774,0.0003848728,0.0002088359],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004219798,"about_ca_system_score_gemma":0.0003499569,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004656143,"about_ca_topic_score_gemma":0.0009331725,"domain_scores_codex":[0.999781,0.00005286321,0.00002625788,0.00004873797,0.0000382913,0.00005299738],"domain_scores_gemma":[0.9995515,0.00005193948,0.0002434525,0.00001656475,0.00004178297,0.00009473981],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004144683,0.0001356099,0.9903717,0.0000176855,0.00004211275,0.0001898204,0.00005248989,0.0001424822,0.0008844747,0.00005598487,0.0002803347,0.007412831],"study_design_scores_gemma":[0.00005434682,0.0006989182,0.9948381,0.00002331715,0.00007231749,0.001510565,0.0002328436,0.0005861759,0.0005570748,0.0001704182,0.001249483,0.00000650441],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984434,0.0005219449,0.00009562074,0.0001035193,0.000006477379,0.000007107309,0.0002134419,0.000002738095,0.0006057002],"genre_scores_gemma":[0.999235,0.0001158551,0.00006090046,0.00005486928,0.00001637159,0.000008394487,0.0003992975,0.000001018572,0.0001084326],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001065328,"threshold_uncertainty_score":0.003563821,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0218112948476391,"score_gpt":0.3361240990998265,"score_spread":0.3143128042521874,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}